Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pep19 for weight control in adults with overweight or obesity
RBR-5gmy8p6Phase 2Not yet recruiting
- Sponsor
- Fundação do ABC
- Start
- Jun 2026
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Pep19 in obesity (3 arms), sponsored by Fundação do ABC. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
Pep19
03
Conditions
obesity
Beyond the preview
Go deeper on RBR-5gmy8p6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-5gmy8p6.